InvestorsHub Logo
Followers 29
Posts 2180
Boards Moderated 0
Alias Born 12/13/2016

Re: None

Monday, 03/18/2024 6:53:13 PM

Monday, March 18, 2024 6:53:13 PM

Post# of 460118
There are enough negative torpedoes on this board to sink a fleet! Meanwhile from the MJFF we read about their research with Anavex 2-73. Be patient and positive!

From the MJFF:

Tracking Drug that Improves Cognition: Anavex Life Sciences is testing a drug with the potential to slow or stop Parkinson’s. ANAVEX2-73 activates the sigma-1 receptor protein, which protects brain cells from harmful stress and toxic protein buildup. After ANAVEX2-73 showed improvement on thinking and memory in people with Parkinson’s disease dementia, the company is studying how the drug works in the brain through imaging scans and blood tests. This can help guide future trials. We previously funded Anavex for laboratory studies toward development of ANAVEX2-73.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News